Finding Better Treatment of Bronchiolitis: A Clinical Trial of Oral Nitazoxanide for the Treatment of Bronchiolitis in Infants Presenting to Hospital Emergency Departments

Summary

Bronchiolitis is an extremely common cause of respiratory illness in infants caused by viral infection.This study evaluates whether treatment with nitazoxanide (NTZ) reduces the duration and severity of respiratory symptoms caused by bronchiolitis. Half of the participants will receive NTZ while the other half will receive a placebo.

Timeline

Start

2016-12

Primary completion

2017-10

Completion

2018-07

Outcome

Outcome not reported

Stopped (Business): “The drug manufacture were unable to produce liquid formulation of the IMP within a reasonable time frame so the funding was relinquished.”

Drugs

Indications